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Activation of transducin-GDP by NaF is mainly mediated by ~~nofluo~de or ~~llo~uo~de complexes acting as GTP y-phosphate analogs. 
In millimolar magnesium, NaF at concentrations above 3 mM is active even in the absence of aluminium or beryllium. This activation has a Hill 
coefficient of 3 with respect o F-, and its rate is linear with respect o M&+ concentrations above 2 mM. Upon fluoride dilution, inactivation 
rate is hundreds of times faster than for aluminofluoride-activated TuGDP. We propose that at high NaF concentrations, 3hydrogen-bonded fluo- 
rides in the y-phosphate site of TaGDP entrap a magnesium counterion and this induces the transconformation to the TaGTP form. 
Fluoride; Magnesium; Transducin; G-protein 
1. INTRODUCTION 
Fluoride activation of transducin and other G- 
proteins is usually due to traces of ~uminium forming, 
in the presence of millimolar NaF or KF, complexes 
such as AlF4 - and AlFs(OH) - [l]. Beryllium, when 
added as BeCl2, also forms complexes uch as BeF3 -. 
These complexes (abbreviated AIFx and BeFx) bind 
with micromolar affinities in the nucleotide site of the 
(Y subunit of transducin (To), next to the bound GDP 
and simulate the presence of the y-phosphate of a GTP 
[2,3]. This induces, as for a GDP/GTP exchange, the 
dissociation of the ‘activated’ Ta subunit from T& 
and, in media of physiological ionic strength, its subse- 
quent solubilization from the membrane. Activation 
also induces a conformational change of TCY which 
results in a 70% increase in its intrinsic tryptophan 
fluorescence [4,5]. While monitoring by this technique 
the kinetics of transducin activation, we observed that, 
at concentrations above 3 mM, NaF without added 
AlCl3 or BeCl2 induced an activation that could not be 
due to aluminium contamination. But our media always 
contained 2 mM magnesium, a regular component of 
the cytoplasmic milieu, which is required for the func- 
tional structure of transducin [6,7]. We therefore sear- 
ched for a possible implication of magnesium in the 
fluoride-dependent activation. Our experiments uggest 
that although magnesium does not form stable com- 
plexes with fluoride, it can cooperate with fluoride to 
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activate transducin, albeit at a much lower affinity than 
Al or Be. 
2. MATERIALS AND METHODS 
All salts were of the highest available purity, with known 
aluminium contaminations in the ppm range. But aluminium con- 
tamination is not quoted on any available commercial NaF sample. 
Our NaF batch from Merck (Suprapur grade) was analyzed by atomic 
absorption spectroscopy and showed a con~mination of 3 X lo-’ 
mole of ~uminium per mole of NaF. Solutions were made and stored 
in plastic containers. TaGDP was solubilized from illuminated bovine 
rod outer segments (ROS) membranes by 200 pM GTP in KC1 120 
mM, MgClz 1 mM, Tris-HCl20 mM, pH 7.5, separated from excess 
nucleotide on Sephadex G-25, and purified on a Pharmacia FPLC 
Polyanion-SI column by elution with a O-660 mM Na2S04 gradient in 
MgS04 10 mM, &mercaptoethanol5 mM, PMSF 0.1 mM, Tris-HC1 
20 mM, pH 7.5, as described previously [S]. For fluorescence 
measurements, the protein solution was diluted 40-200 times, down 
to 50 nM, in a 10X10 mm cuvette containing 1.6 ml standard ‘TKM 
buffer’: Tris-HC120 mM, pH 7.5, KC1 120 mM, MgClz 2 mM, DTT 
1 mM, and appropriate amounts of NaF, AlCl, or BeCl2. 
Measurements were performed at 25C, with stirring, in a Shimadzu 
RF 5000 fluorimeter with excitation at 284 nm and emission at 340 nm 
bandwidths 1.5 and 30 mm, respectively). 
3. RESULTS 
Upon activation of purified TaGDP subunits of 
transducin, large variations of tryptophan fluorescence 
are observed, which allow precise estimates of kinetic 
constants in the range from 1 to 10e4 s-r (Fig. 1). All 
incubations and measurements of Fig. 1 were perform- 
ed in our standard TKM buffer (containing 2 mM 
MgCl2). Traces a and b illustrate the requirement of 
micromolar, beryllium or aluminium for activation of 
TaGDP by 1 mM NaF. In both cases the fluorescence 
change goes to saturation and is not increased by fur- 
ther addition of fluoride. The kinetics of this activation 
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Fig. 1. Kinetics of fluorescences changes correlated with transducin 
activation or deactivation. (a, b, c) Activation kinetics; 50 nM solu- 
tions pf TaGDP in TKM (Tris, KCl, MgClr) buffer are activated by 
injections of NaF, AlCls or BeCl2 to the indicated concentrations. 
(d,e,f,g) Deactivation kinetics and controls; concentrated solutions of 
TaGDP that have been activated at saturation by incubating for 25 
min at 25C in TKM buffer with 3 mM NaF and 40 fl AlCls (d), or 
3 mM NaF and 40 M BeClr (e) are diluted 200-fold (50 nM final) in 
TKM buffer or (f,g) diluted in their respective incubation medium for 
controls. (h,i) Deactivation kinetics and control for transducin ac- 
tivated by incubation (25 min, 2%) in TKM buffer with 32 mM NaF; 
(h) dilution (lOO-fold, 50 mM final) in TKM buffer or (i) in TKM 
bufer and 32 mM NaF. (j) Evolution of transducin upon its dilution 
(lOO-fold, 50 nM final) from TKM buffer with 32 mM NaF alone into 
TKM buffer with 1 mM NaF and 10 FM AlClr. 
depend linearly on the concentration of Al or Be and on 
a complex manner on that of fluoride: this reflects the 
dependence on fluoride concentration of the formation 
of the activating complexes AlFx and BeFx [9, lo]. The 
difference in kinetics between traces a and b, for the 
same addition of AlC13 and BeC12, respectively, il- 
lustrate these different dependences and possibly dif- 
ferent affinities of AlFx and BeFx complexes for the y- 
phosphate site. This will be analyzed in detail 
elsewhere, but we observed that a fluorescence increase 
of comparable kinetics could be obtained upon addition 
of 15 mM NaF alone; the fluorescence was not enhanc- 
ed by further addition of BeClz (Fig. lc) or AlCl3 (not 
shown). Aluminium contamination from all the salts 
present in this concentrated NaF solution was estimated 
to be less than 0.47 PM. This was too low, by more than 
a factor of 10, to account for the observed activation 
kinetics. The same activation by 15 mM of NaF alone 
was observed after 1 mM EDTA + 1 mM MgCl2 had 
been added to the bufer to chelate aluminium while 
keeping free magnesium constant. This strongly sug- 
gested that aluminium was not involved in this activa- 
tion. 
Deactivation kinetics were measured upon diluting 
into NaF-free TKM buffer, concentrated solutions of 
TCY that had previously been activated at saturation by 
25 min incubation with 3 mM NaF and 40 PM AlC13 (d) 
or BeC12 (e), or with 32 mM NaF alone (h). For con- 
trols, dilutions were also made into the solutions used 
for activation. Transducin that had been activated by 
AlFx or BeFx became deactivated with half-times of 
500 and 5000 s, respectively (f.g). Deactivation took less 
than 5 s, that is a 2-3 orders of magnitude shorter half- 
time, for transducin activated by high concentration of 
NaF without added AlCl3 (h). This difference in deac- 
tivation kinetics suggests that the activated state induc- 
ed by NaF without added AlCI3 is in some ways dif- 
ferent from that induced by AlFx or BeFx. All deactiva- 
tions could be fully reversed by readdition of the 
original activating salts (d,e,h). In another experiment, 
transducin that had been activated in 32 mM NaF 
without added AlCl3 was diluted lOO-fold into a cuvette 
with TKM buffer containing 1 mM NaF and 10 PM 
AlCI3. This NaF concentration would be low to induce 
activation without added AlCl3 (see Fig. 1 la and b). A 
biphasic trace (j) was then observed, with a fast decay- 
ing phase, as in (h), followed by a rising phase that 
parallels that observed when injecting inactivated 
TaGDP into the same medium. Thus, whatever had ac- 
tivated transducin in concentrated NaF was released 
before activation by AlFx took place. This further pro- 
ves that AlFx formed from contaminant, aluminium in 
the concentrated NaF solution was not responsible for 
the previous activation. 
Another test for the activation of transducin by high 
concentrations of NaF without added AlCl3, was the 
solubilisation of Ta from ROS membrane in TKM buf- 
fer (Fig. 2a). Full solubilisation was, however, not 
reached even with our maximal concentration of 32 mM 
NaF (pF 1.5). This apparently conflicts with the 
saturated fluorescence changes induced by 32 mM NaF 
on purified TarGDP (Fig. lh). But the solubilisation test 
is made on the membrane-bound holoenzyme. TaGDP- 
T@y and T@y probably affects the equilibrium activa- 
tion of Ta by aluminium-free NaF as it affects its ac- 
tivation by AlFx [3]. Solubilization by NaF without 
added AlC3 required the presence of GDP in the 
nucleotide site of TCY, and was inhibited upon substitu- 
tion with GDPpS (Fig. 2b). This suggests that, as for 
AlFx or BeFx, the activator in this case interacts with 
the fl phosphate of GDP in the TCY nucleotide site. 
Magnesium being the only divalent metal present in 
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Fig. 2. Activation of transducin, monitored through the solubilization 
of Ta from ROS membranes. The membranes were illuminated, 
washed free of soluble proteins by sedimentation in 5 mM Tris HCl, 
pH 7.5, and resuspended in TKM buffer with 100 CM GDP and the 
indicated concentrations of NaF and AX13 (a) or (b) resuspended in 
TKM buffer with 32 mM NaF alone or with 100 FM GDP or 100 fl 
GDP@. The suspensions were incubated for 6 min at ZOC and 
sedimented. The solubilized Tot was assayed in the supernatants by 
densitometry of Coomassie blue-stained SDS PAGE. 
the buffer, we investigated its possible influence on the 
kinetics of activation by NaF (Fig. 3). Without AlCb or 
BeQ the activation kinetics varied linearly with 
magnesium in the range from 2 to 10 mM, at 3 mM 
NaF, where this activation was slow and partial, as well 
as at 15 mM NaF, where it was fast and saturated. This 
strongly suggests that a how-af~nity binding of one 
Mg2 + is required for activation. Linearity is lost below 
2 mM magnesium, but this is probably due to another 
role of magnesium which binds with better than 10m4 M 
affinity to GDP in the nucleotide site, in a fluoride- 
independent way, and is required for the proper func- 
tioning of the protein [6,7]. In the presence of AK13 or 
BeCl2, at both 3 and 15 mM NaF concentrations, the 
activation kinetics plots parrallel the corresponding 
ones without these additions. Thus, if one subtracts the 
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Fig. 3. Dependence on magnesium of NaPinduced activation of 
transducin. The activation rates are deduced from the initial slopes of 
the fluorescence kinetics curves observed after injection of 50 nM 
TaGDP in a buffer untying 120 mM KCl, 20 mM Tris-HCl, pH 
7.5, the indicated amount of MgCl2 and (%) 3 mM NaF, (0) 3 mM 
NaF + 10 FM BeCl2 (El) 15 mM NaF, (=) 15 mM NaF + 10 CM 
BeCl2. 
contribution of NaF in the absence of AK3 or BeC12, 
the activation rate due to AlFx or BeFx appears insen- 
sitive to magnesium concentrations above 2 mM. 
Fluoride anions do not combine with magnesium ca- 
tions to form stable complexes, as they do with 
aluminium or beryllium: the two ions remain 
dissociated in solution. The cont~butions of fluoride 
and magnesium to the activation process can therefore 
be analyzed separately. The activation dose-response 
curve with respect to fluoride, at a fixed 2 mM 
magnesium concentration, shows a clear cooperativity, 
with a Hill coefficient of 3 (Fig. 4). This suggests that at 
least 3 fluoride anions are implicated in the activation 
process. 
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Fig. 4. Activation of transducin in TKM buffer (with 2 mM MgCl2 by 
NaF without added AlCI3 or BeCl2. Dose-response curve with respect 
to fluoride concentration and corresponding Hill plot. 
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Fig. 5. Models for insertion of fluorometallic omplexes in the nucleotide site of TcYGDP. Preformed AIF, or BeF, tetrahedral complexes interact 
by a bimolecular eaction with the terminal oxygen of the GDP B-phosphate. Fluoride and magnesium ions, which do not form stable complexes 
in solution, can also bind separately in the site to form a y-phosphate analogue. The dotted lines represent hydrogen bonds or weak ionic bonds. 
4. DISCUSSION 
That at high NaF concentrations ome activation of 
G-proteins might not be attributable to aluminium con- 
tamination, had already been suspected by Higashijima 
et al. [4], who even mentioned magnesium as a possible 
candidate. Our kinetic data demonstrate that, at NaF 
concentrations above 5 mM, activation can indeed be 
induced by the binding of one magnesium cation and 3 
fluoride anions to ToGDP. The activation process is 
sensitive to the presence of GDP and particularly to its 
terminal oxygen on the &phosphate; it is very quickly 
reversed upon depletion of fluoride in the medium. All 
this concurs with the model shown on Fig. 4. The Mg-- 
F ionic bonding length (1.72 A as measured in MgF2 
crystals) is close enough to the P-O bond length 
(1.56-l .6 A) to make the model sterically plausible. The 
steric analogy with our previous model for 
aluminofluoride or beryllofluoride activation is evi- 
dent, but the two activation processes are dynamically 
very different: instead of a preformed tetrahedral com- 
plex binding with high affinity (low off-rate) in the y- 
phosphate site of transducin, one assumes here the 
hydrogen-bonding, most probably to the donor groups 
that normally bind the y-phosphate oxygens, of 3 
fluoride anions which in turn entrap a magnesium 
counterion (Fig. 5). The affinities are low (high off- 
rate), both for the fluorides, as indicated by the fast in- 
activation rate in low fluoride, and for the magnesium 
(data not shown). 
This new model complements our previous proposal 
for the activation by aluminofluoride or beryllofluoride 
complexes. Aluminofluoride complexes probably re- 
280 
main the predominant vehicle for NaF activation of G- 
proteins if no special care is taken to eliminate 
aluminium from solutions, when magnesium and 
fluoride concentrations do not exceed the millimolar 
range. It remains to investigate whether the validity of 
this fluoride + magnesium model extends to the broad 
range of nucleotide- or phosphate-binding proteins 
(ATPases, phosphatases) which are sensitive to 
aluminofluorides [lo]. 
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